Basiliximab

Drug Index

Basiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. Contents 1 Uses 2 Mechanism of action 3 Chemistry 4 History 5 See also 6 References and notes Uses Basiliximab is an immunosuppressant agent used to prevent immediate transplant rejection in people who are receiving kidney transplants, in combination with o...

Basiliximab

Basiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. Contents 1 Uses 2 Mechanism of action 3 Chemistry 4 History 5 See also 6 References and notes Uses Basiliximab is an immunosuppressant agent used to prevent immediate transplant rejection in people who are receiving kidney transplants, in combination with o...

NDC Database

Simulect 20 mg/5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation ## Package Codes: 0078-0331-84 ## Active Ingredients: Basiliximab

NDC Database

Simulect 10 mg/2.5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation ## Package Codes: 0078-0393-61 ## Active Ingredients: Basiliximab